News | December 04, 2007

New Research at UCSD Shows Benefits of SAVI Breast Brachytherapy

December 5, 2007 - The Cianna Medical SAVI applicator, an advanced treatment for breast cancer, provides multiple benefits for patients, breast surgeons, and radiation oncologists, according to research performed at the Rebecca and John Moores UCSD Cancer Center and presented at the annual meeting of the Radiological Society of North America.

The research was headed by Catheryn Yashar, M.D., Assistant Professor and Chief of Breast and Gynecological Services in the UCSD Department of Radiation Oncology.
An advancement in breast conservation therapy (lumpectomy plus radiation), the SAVI applicator is a single-entry, multi-catheter device that delivers partial breast irradiation. SAVI reduces the course of treatment time from six weeks to just five days. Its unique design may expand the benefits of breast conservation therapy to a larger group of women.

Dr. Yashar and her colleagues reported that treatment with the applicator is effective in multiple ways:
- SAVI is simple to insert, using local anesthesia and ultrasound guidance.
- The applicator provides excellent coverage of the tumor bed.
- SAVI makes it possible to conform the radiation dosage to the targeted area, offering better protection to healthy structures such as the skin, chest wall, and lungs.
- Daily quality assurance can be done with scout films (ordinary X-rays) rather than CT scans, which substantially reduces the patient’s exposure to radiation and is more convenient.
-The applicator rarely moves between treatments, which means the original treatment plan remains valid throughout the course of treatment. The fact that SAVI stays in place after insertion is also the reason CT scans are not needed for quality assurance.
-SAVI is nearly painless to remove after treatment is concluded, so no anesthesia is needed.
-The treatment is well-tolerated by patients.
-SAVI has produced outstanding early cosmetic results.

For more information: www.ciannamedical.com

Related Content

Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System
Technology | Breast Biopsy Systems | July 24, 2019
Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its...
Varian Purchasing Embolic Bead Assets from Boston Scientific
News | Interventional Radiology | July 03, 2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...